BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Exelixis, Inc. (NQ: EXEL)
4.490 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
(EXEL) Community Analysis from
May 21, 2013
(Penny Stock DD, 10/24/11)
 (ADLR: News ) is jumping 135 percent to $4.51 as it agreed to be acquired by Cubist Pharmaceuticals, Inc. (CBST) for $4.25 per share in cash, or approximately $190 million on a...(read more)
(, 6/5/11)
Exelixis (EXEL) is at the ASCO conference in Chicago and over the weekend, they released phase II study results for CABO and its effects on ovarian cancer.  Monday afternoon, they will be...(read more)
(, 5/8/11)
It has been a while since I put together chart analysis for biotechnology company Exelixis (EXEL), so I made it a point to do this before the market opens on Monday.  EXEL is in a clear downtrend that did breach the bottom of the trading range for one day and bounced on Friday along with [...]
Exelixis (EXEL) Company Overview

There is no analysis for EXEL yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here